|
Real-time Estimate
Cboe BZX
10:02:31 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 13.28 USD | +14.88% |
|
-0.52% | -11.28% |
| 06:20am | TD Cowen Initiates Freenome at Buy With $17 Price Target | MT |
| 08-17 | Sector Update: Healthcare Stocks Softer Late Afternoon | MT |
Projected Income Statement: Freenome, Inc.
Annual
Quarterly
Annual
Quarterly
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Net sales 1 | 69.23 | 103.4 | 178.1 |
| Change | - | 49.39% | 72.22% |
| EBITDA 1 | -157.6 | -204.5 | -270.6 |
| Change | - | -29.78% | -32.3% |
| EBIT 1 | -186.3 | -231.2 | -298.1 |
| Change | - | -24.11% | -28.92% |
| Interest Paid 1 | -8.851 | -19.6 | -19.6 |
| Earnings before Tax (EBT) 1 | -113 | -259.9 | -212.5 |
| Change | - | -130.12% | 18.23% |
| Net income 1 | -202.1 | -283 | -303.2 |
| Change | - | -40.06% | -7.14% |
| Announcement Date | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: Freenome, Inc.
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Net Debt | - | - | - |
| Change | - | - | - |
| Announcement Date | - | - | - |
Estimates
Cash Flow Forecast: Freenome, Inc.
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| CAPEX 1 | 21.26 | 23.93 | 26.31 |
| Change | - | 12.59% | 9.96% |
| Free Cash Flow (FCF) 1 | -105 | -138 | 81 |
| Change | - | -31.43% | 158.7% |
| Announcement Date | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: Freenome, Inc.
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
Profitability | |||||
| EBITDA Margin (%) | - | - | -227.65% | -197.76% | -151.92% |
| EBIT Margin (%) | - | - | -269.12% | -223.56% | -167.36% |
| EBT Margin (%) | - | - | -163.15% | -251.31% | -119.32% |
| Net margin (%) | - | - | -291.88% | -273.63% | -170.24% |
| FCF margin (%) | - | - | -151.66% | -133.42% | 45.47% |
| FCF / Net Income (%) | - | - | 51.96% | 48.76% | -26.71% |
Profitability | |||||
| ROA | -34.21% | -26.38% | - | - | - |
| ROE | -90.3% | -107.26% | - | - | - |
Financial Health | |||||
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - |
Capital Intensity | |||||
| CAPEX / Current Assets (%) | - | - | 30.7% | 23.14% | 14.77% |
| CAPEX / EBITDA (%) | - | - | -13.49% | -11.7% | -9.72% |
| CAPEX / FCF (%) | - | - | -20.24% | -17.34% | 32.49% |
Items per share | |||||
| Cash flow per share 1 | - | - | - | - | - |
| Change | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - |
| Change | - | - | - | - | - |
| Book Value Per Share 1 | - | - | - | - | - |
| Change | - | - | - | - | - |
| EPS 1 | - | - | -5.61 | -2.575 | -2.665 |
| Change | - | - | - | 54.1% | -3.5% |
| Nbr of stocks (in thousands) | - | - | 112,858 | 112,858 | 112,858 |
| Announcement Date | - | - | - | - | - |
1USD
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | -2.32x | -5.05x |
| PBR | - | - |
| EV / Sales | 21.2x | 14.2x |
| Yield | - | - |
EPS & Dividend
Y-o-Y evolution of P/E
Sell
Buy

Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.00USD
Average target price
17.33USD
Spread / Average Target
+33.33%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FRNM Stock
- Financials Freenome, Inc.
Select your edition
All financial news and data tailored to specific country editions
















